Singapore SARS case raises concerns

WHO expert says a global biosecurity system needed to keep labs in shape

Written byRobert Walgate
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Inadequate training and poor laboratory practice in a Singapore lab resulted in a 27-year-old postdoctoral student coming down with the first case of severe acute respiratory syndrome for months, reports from the World Health Organization and Singapore Ministry of Health said this week.

The postdoc had been studying West Nile virus in a biosafety level three (BSL3) laboratory at the Singapore Environmental Health Institute, where the severe acute respiratory syndrome (SARS) virus was also under investigation.

Although this case poses no public health threat, the Singapore experience highlights concerns about the potential risks arising from labs, said Klaus Stöhr, a scientist with World Health Organization (WHO) Communicable Disease Surveillance and Response.

"We have done so much to control the disease...and a minor mistake in a lab could take us back to square one," he told The Scientist.

"Very many labs around the world have been working with the virus, not ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery